Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug development
Biotech
Alveus emerges to tackle obesity drug pitfalls with $160M
Looking to improve on current obesity drugs, Alveus Therapeutics has debuted with nearly $160 million and an impressive roster of executives.
Fraiser Kansteiner
Jan 8, 2026 7:30am
Pharma's 'urgent need for reinvention': PwC's call to action
Jan 8, 2026 6:00am
FDA qualifies 1st AI drug development tool in MASH
Dec 9, 2025 12:12pm
Value of AI biotechs nearly double that of peers: PitchBook
Nov 26, 2025 10:34am
Zealand pumps brakes on development of dual GLP-1/GLP-2 agonist
Nov 13, 2025 9:52am
Boehringer digs in on ADCs with $991M AimedBio licensing accord
Oct 15, 2025 10:05am
